Loading...
01/11 03:34
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals a decline in key financial metrics like gross margins, operating income, and EPS, with additional currency headwinds and increased expenses. Although management provides optimistic guidance for future recovery, the Q&A section indicates skepticism about margin improvements and the impact of the Fem Care sale. The strategic plan's focus on debt reduction and brand investments doesn't alleviate immediate financial pressures. Given the market cap of ~$2 billion, the negative sentiment is likely to result in a stock price decline of -2% to -8% over the next two weeks.
Organic Net Sales Growth (Q4) 2.5% growth year-over-year. Reasons: Strong performance in international markets and stabilization in North America.
International Organic Net Sales Growth (Q4) 6.9% growth year-over-year. Reasons: Broad-based growth across all segments, driven by volume and price gains.
North America Organic Net Sales Decline (Q4) 0.6% decline year-over-year. Reasons: Growth in Sun Care, Wet Ones, and Grooming offset by declines in Wet Shave.
Adjusted Gross Margin Rate (Q4) Decreased by 330 basis points year-over-year. Reasons: Higher-than-anticipated inventory adjustments, increased trade mix, and unfavorable inflation and tariffs.
Adjusted Operating Income (Q4) $40.3 million (7.5% of net sales), down from $56 million (10.8% of net sales) year-over-year. Reasons: Lower gross margins, FX headwinds, and incremental brand investments.
Adjusted Earnings Per Share (Q4) $0.68, down from $0.72 year-over-year. Reasons: Currency headwinds and lower gross margins.
Adjusted EBITDA (Q4) $59.4 million, down from $78.9 million year-over-year. Reasons: Unfavorable currency impact and lower gross margins.
Net Cash Provided by Operating Activities (Fiscal 2025) $118.4 million, down from $231 million year-over-year. Reasons: Lower earnings and higher working capital build.
Organic Net Sales Decline (Fiscal 2025) 1.3% decline year-over-year. Reasons: Weaker-than-anticipated Sun Care season and increased promotional levels in North America.
Adjusted Gross Margin Rate (Fiscal 2025) Decreased by 110 basis points year-over-year. Reasons: Core inflation, unfavorable mix, and increased promotional levels.
Adjusted Operating Profit (Fiscal 2025) Decreased by $48 million (18%) year-over-year. Reasons: Gross margin rate declines, higher brand marketing investments, and unfavorable currency impact.
Adjusted Operating Margin (Fiscal 2025) 9.9%, down 200 basis points year-over-year. Reasons: Declines in gross margin rate and higher marketing investments.
Billie expansion: Expanded Billie to Australia.
Bulldog premium skin care: Entered premium skin care across Europe.
Schick Progista: Launched in Japan as a premium skin care product.
Cremo range: Broadened in the United States and Europe, driving significant sales growth.
Hawaiian Tropic: Strong growth due to a successful marketing campaign, updated formulations, and on-trend branding.
International market growth: International markets, representing 40% of global sales, delivered strong growth for the fourth consecutive year. Europe generated its third straight year of growth, and Greater China delivered double-digit growth.
North America stabilization: North American markets showed progress with relatively flat sales performance and improvements in consumption and market share.
Supply chain optimization: Delivered over 270 basis points in gross savings in fiscal 2025 and expects 310 basis points in fiscal 2026. Actions include reducing complexity, improving customer service, shortening lead times, and lowering inventory.
North American Wet Shave optimization: Streamlining operations, reducing duplication, and investing in blade excellence and next-generation automation.
Divestiture of Feminine Care business: Key step to transform Edgewell into a more focused, agile, and consumer-driven personal care company.
U.S. commercial transformation: Simplified structure, increased investment in five focus brands, and implemented organizational redesign to improve decision-making and accountability.
Tariffs and Inflation: The company faces significant headwinds from tariffs and inflation, with a net tariff impact of $25 million expected in fiscal 2026. Tariff mitigation efforts have proven challenging due to the inability to source certain materials like steel and aluminum elsewhere.
Foreign Exchange Volatility: Currency fluctuations have negatively impacted earnings, with a $19 million unfavorable impact on adjusted EPS in the fourth quarter of fiscal 2025.
Geopolitical Tensions: Geopolitical uncertainties have stressed the global supply chain and contributed to financial pressures.
North America Business Challenges: The North American market has shown flat or declining sales in key categories like Wet Shave, and the business is undergoing a complex transformation to stabilize and return to growth.
Sun Care Season Performance: Weaker-than-expected sun care seasons in North America and parts of Latin America have negatively impacted financial performance.
Complex U.S. Structure: The U.S. commercial organization was previously too complex, leading to slow decision-making and underinvestment in key capabilities.
Inventory and Trade Adjustments: Higher-than-anticipated year-end inventory adjustments and trade promotions have negatively impacted gross margins.
Consumer Uncertainty: Cautious consumer spending on discretionary items has created a challenging macroeconomic environment.
Feminine Care Business Divestiture: The planned divestiture of the Feminine Care business introduces risks related to stranded overhead costs and transition income.
Fiscal 2026 Organic Net Sales Growth: Expected to range from down 1% to up 2%, with mid-single-digit growth in international markets and flat to slightly down performance in North America.
Gross Margin: Anticipated to increase by 60 basis points year-over-year, driven by 310 basis points of productivity savings and tariff mitigation, partially offset by inflation and negative mix.
Adjusted EBITDA: Projected to be in the range of $290 million to $310 million, approximately flat compared to the prior year at the midpoint.
Adjusted EPS: Expected to range between $2.15 and $2.55, reflecting higher taxes and interest expenses in the first half of the fiscal year.
Free Cash Flow: Anticipated to range from $115 million to $145 million, supported by improvements in working capital.
Capital Allocation: Focus on reducing debt leverage, continuing dividends, and share repurchases to offset dilution. Proceeds from the Feminine Care divestiture will be directed towards debt reduction and investment in core brands and growth initiatives.
Tariff Impact: Net tariff impact after mitigation efforts is expected to be approximately $25 million, with gross impact of $37 million. Mitigation efforts include productivity initiatives and sourcing optimization.
Advertising and Promotional Spending: Planned increase to approximately 11.8% of net sales, up 70 basis points year-over-year, to support brand activation and growth.
Phasing of Financial Performance: Two-thirds of adjusted EBITDA and three-quarters of adjusted EPS are expected in the second half of fiscal 2026, with Q1 adjusted EPS below prior year.
Quarterly Dividend Payout: Declared $0.15 per share dividend for the fourth quarter.
Share Repurchase Program: Returned approximately $7 million to shareholders via dividend and achieved target of approximately $90 million in share repurchases for fiscal year by the end of Q3.
The earnings call reveals a decline in key financial metrics like gross margins, operating income, and EPS, with additional currency headwinds and increased expenses. Although management provides optimistic guidance for future recovery, the Q&A section indicates skepticism about margin improvements and the impact of the Fem Care sale. The strategic plan's focus on debt reduction and brand investments doesn't alleviate immediate financial pressures. Given the market cap of ~$2 billion, the negative sentiment is likely to result in a stock price decline of -2% to -8% over the next two weeks.
The earnings call reveals declining financial metrics, including a 4.2% drop in organic net sales and a significant decrease in operating income and earnings per share. The Q&A section highlights concerns about cash flow, reliance on international growth, and lack of clear guidance for fiscal '26. Despite some positive developments, such as balanced inventory levels and international growth, the overall sentiment is negative due to the weak financial performance and vague future outlook. Given the company's small market cap, this could lead to a stock price decline of -2% to -8%.
The earnings call presents a mixed picture: International growth and increased gross margin are positives, but North American sales declined, operating income decreased, and consumer confidence is low. The Q&A reveals management's confidence in future growth, but uncertainties remain with tariffs and economic factors. The market cap suggests moderate volatility. Overall, the positives and negatives balance out, suggesting a neutral sentiment with potential for slight positive movement if international growth and strategic investments yield results.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
